Literature DB >> 7556994

The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination.

G Dahlquist, L Gothefors.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7556994     DOI： 10.1007/bf03035306

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  5 in total

1.  The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989.

Authors:  V Romanus; A Svensson; H O Hallander
Journal:  Tuber Lung Dis       Date:  1992-06

2.  Prevention of overt diabetes and insulitis in NOD mice by a single BCG vaccination.

Authors:  M Harada; Y Kishimoto; S Makino
Journal:  Diabetes Res Clin Pract       Date:  1990-01       Impact factor: 5.602

3.  Prevention of type I diabetes in NOD mice by adjuvant immunotherapy.

Authors:  M W Sadelain; H Y Qin; J Lauzon; B Singh
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

4.  The Swedish childhood diabetes study--results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders.

Authors:  G Dahlquist; L Blom; T Tuvemo; L Nyström; A Sandström; S Wall
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

5.  Effect of adjuvant therapy on development of diabetes in mouse and man.

Authors:  N Shehadeh; F Calcinaro; B J Bradley; I Bruchim; I Bruchlim; P Vardi; K J Lafferty
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321
  5 in total
  10 in total

1.  Association between type 1 diabetes and Haemophilus influenzae type b vaccination: birth cohort study.

Authors:  M Karvonen; Z Cepaitis; J Tuomilehto
Journal:  BMJ       Date:  1999-05-01

Review 2.  Immunisation and type 1 diabetes mellitus: is there a link?

Authors:  M Hiltunen; M Lönnrot; H Hyöty
Journal:  Drug Saf       Date:  1999-03       Impact factor: 5.606

3.  Vaccines modulate IDDM.

Authors:  J B Classen; D C Classen
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Cohort Profile: The Québec Birth Cohort on Immunity and Health (QBCIH).

Authors:  Marie-Claude Rousseau; Mariam El-Zein; Florence Conus; Marie-Elise Parent; Andrea Benedetti
Journal:  Int J Epidemiol       Date:  2018-08-01       Impact factor: 7.196

Review 5.  Environmental risk factors for type 1 diabetes.

Authors:  Marian Rewers; Johnny Ludvigsson
Journal:  Lancet       Date:  2016-06-04       Impact factor: 79.321

Review 6.  Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.

Authors:  T Staeva-Vieira; M Peakman; M von Herrath
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

Review 7.  Progress in immune-based therapies for type 1 diabetes.

Authors:  M von Herrath; M Peakman; B Roep
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

Review 8.  Influences of pre- and postnatal nutritional exposures on vascular/endocrine systems in animals.

Authors:  J J Hoet; S Ozanne; B Reusens
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

Review 9.  Adverse effect of high glucose concentration on stem cell therapy.

Authors:  Najmaldin Saki; Mohammad Ali Jalalifar; Masoud Soleimani; Saeideh Hajizamani; Fakher Rahim
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2013

10.  Type 1 diabetes in a Nigerian family - occurrence in three out of four siblings: A case report.

Authors:  Michael Adeyemi Olamoyegun; Oluwabukola Ayodele Ala
Journal:  World J Diabetes       Date:  2019-10-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.